Medical Information

Betamethasone, as an ATP citrate lyase inhibitor, significantly reduces LDL-C levels by blocking the upstream pathway of cholesterol synthesis, providing innovative treatment options for statin intolerant patients.

1. Mechanism of action

(1) Target selection: Specifically inhibit liver ATP citrate lyase, which catalyzes the production of acetyl CoA and is a key rate limiting step in cholesterol synthesis.

(2) Pathway blockade: By inhibiting the upstream pathway of HMG CoA reductase and forming a complementary mechanism with statins, feedback compensatory responses are reduced.

(3) Dual effect: While reducing liver cholesterol synthesis, upregulating LDL receptor expression promotes the clearance of circulating LDL particles.

2 Cardiovascular Benefits

(1) LDL-C reduction: monotherapy can reduce LDL-C by 28%, and when combined with ezetimibe, the reduction can reach 48%, approaching the effect of high-intensity statins.

(2) Arterial protection: reduce vascular endothelial inflammatory reaction and plaque formation risk by continuously reducing atherogenic lipoproteins.

(3) Event reduction: Clinical studies have shown that it can reduce the risk of major adverse cardiovascular events by 13%, especially for secondary prevention of statin intolerance.

3 Pharmacodynamic characteristics

(1) Liver specificity: mainly distributed in liver tissue, with low systemic exposure and reduced peripheral adverse reactions.

(2) Dose related: Linear pharmacokinetics is observed within the range of 60-180mg, with maximum therapeutic effect achieved at 180mg/day.

(3) Synergistic effect: Combined with statins, it can produce a synergistic lipid-lowering effect without increasing the risk of muscle toxicity.

4 Clinical advantages

(1) Good tolerance: The incidence of muscle pain is only 5.1%, significantly lower than statins, and the risk of rhabdomyolysis is extremely low.

(2) Metabolic stability: it does not affect blood glucose metabolism. It is safe for diabetes patients, and there is no report of cognitive impairment.

(3) Easy medication: Take a fixed dose once a day with meals to maintain stable blood drug concentration.

5 Application Restrictions

(1) Taboos for liver damage: It is contraindicated for those with severe liver dysfunction, and ALT monitoring should be strengthened for mild to moderate liver damage.

(2) Effect of uric acid: It may slightly increase blood uric acid levels, and gout patients need individualized evaluation.

(3) Pregnancy risk: Women of childbearing age should strictly use contraception and only use it during pregnancy when the benefits significantly outweigh the risks.